Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Auto and Transport Industry News RattanIndia backed Revolt appoints Jenender Anand as new CEO RattanIndia Enterprises Limited said that its subsidiary Revolt Motors (Revolt Intellicorp) has appointed Jenender Anand as its new… bySrinathSeptember 14, 2021
